June 2020 FDA Recall Drug by Remedyrepack Inc.
D-1387-2020 - FAILED DISSOLUTION SPECIFICATION

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on June 29, 2020 for the product Drug. The FDA reported the reason for recall as failed dissolution specification. The product was distributed in Product was distributed to MN. and the recall is currently terminated.

Recall Number: D-1387-2020

Reason for Recall
FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.
Initiated
06-29-2020
Reported
07-22-2020
Quantity
498 tablets

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed to MN.
Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.

Batch or Lot Expiration Information

Lot# : B0796217-020920, Exp. Date: 02/28/2021